Literature DB >> 29941222

The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis.

Milad Sabzevary-Ghahfarokhi1, Mojtaba Shohan1, Hedayatollah Shirzad2, Ghorbanali Rahimian3, Amin Soltani4, Mahdi Ghatreh-Samani1, Fatemeh Deris5, Nader Bagheri1, Mohammedhadi Shafigh3, Kamran Tahmasbi6.   

Abstract

BACKGROUND: Reactive oxygen species (ROS) is one of the pathogenic factors responsible for intestinal injury in Ulcerative colitis (UC). Nuclear factor erythroid-2 related factor 2 (Nrf2) plays a critical role against ROS factors to conserve epithelial integrity. This study aimed to localize Nrf2 and IL-17A protein in the inflamed mucosa of patients with ulcerative colitis. The gene expression of Nrf2 was also correlated with GST-A4 and PRDX1.
MATERIALS AND METHODS: A total of 20 patients and 20 healthy controls with definite UC based on the clinical criteria were enrolled for this study. The expression pattern of Nrf2 and IL-17A protein was compared in inflamed and non-inflamed colonic biopsies by immunohistochemical staining. Nrf2, GST-A4 and PRDX1 gene expression were determined by real-time polymerase chain reaction (RT-PCR).
RESULTS: In inflamed colonic biopsies, an increased level of Nrf2 protein factor was detected in epithelial cells. Conversely, IL-17A protein was presented more in mononuclear cells in mucosa and lamina propria regions. A significant increase of Nrf2, GST-A4 gene expression was observed in both mild and severe patients with ulcerative colitis. GST-A4 gene expression indicated a high exponential rate in logistic regression.
CONCLUSION: Oxidative stress in inflamed colonic tissue can induce Nrf2 gene expression. The performance of Nrf2 transcription factor may lead to the induction of GST-A4 and PRDX1. IL-17A is less detected in intestinal inflammation, presenting Nrf2 factor. The present findings suggest that Nrf2 function in the gut plays a role in arresting both inflammatory response and oxidative damages of UC.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  GST-A4; Nrf2; Oxidative stress; PRDX1; Ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 29941222     DOI: 10.1016/j.prp.2018.06.001

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  The extract from the roots of Rose odorata sweet var. gigantean (Coll. et Hemsl.) Rehd. et Wils attenuates DSS-induced ulcerative colitis by regulating the Nrf2/NF-κB signaling pathways.

Authors:  Xinyu Li; Rui Liu; Yanmin Zhao; Naying Gao; Xin Jin; Xiaoxia Gao; Tan Li; Dailin Liu
Journal:  RSC Adv       Date:  2020-03-04       Impact factor: 4.036

2.  Protective effect of Gloeostereum incarnatum on ulcerative colitis via modulation of Nrf2/NF‑κB signaling in C57BL/6 mice.

Authors:  Xiao Li; Xin Liu; Yongfeng Zhang; Yaqin Zhang; Shuyan Liu; Nan Zhang; Yu Li; Di Wang
Journal:  Mol Med Rep       Date:  2020-08-05       Impact factor: 2.952

3.  Silencing of peroxiredoxin 1 expression ameliorates ulcerative colitis in a rat model.

Authors:  Na Wu; Xinchong Du; Zhao Peng; Zetian Zhang; Lijun Cui; Duo Li; Rui Wang; Maoyuan Ma
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

4.  Exploration of the Potential Mechanisms of Wumei Pill for the Treatment of Ulcerative Colitis by Network Pharmacology.

Authors:  Jinke Huang; Yijun Zheng; Jinxin Ma; Jing Ma; Mengxiong Lu; Xiangxue Ma; Fengyun Wang; Xudong Tang
Journal:  Gastroenterol Res Pract       Date:  2021-12-21       Impact factor: 2.260

5.  Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats.

Authors:  Lin Zhou; Fengjuan Yan; Rui Jiang; Jing Liu; Limin Cai; Yongchen Wang
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

Review 6.  Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.

Authors:  Min-Ji Kim; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

7.  Gegen Qinlian Decoction Relieves Ulcerative Colitis via Adjusting Dysregulated Nrf2/ARE Signaling.

Authors:  Chuan Lin; Zehua Zhou; Lijun Zhang; Hongqing Wang; Jie Lu; Xinhong Wang; Rui An
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-25       Impact factor: 2.650

8.  Polyphenolic Maqui Extract as a Potential Nutraceutical to Treat TNBS-Induced Crohn's Disease by the Regulation of Antioxidant and Anti-Inflammatory Pathways.

Authors:  Tamara Ortiz; Federico Argüelles-Arias; Matilde Illanes; Josefa-María García-Montes; Elena Talero; Laura Macías-García; Ana Alcudia; Victoria Vázquez-Román; Virginia Motilva; Manuel De-Miguel
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.